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Abstract
Posttraumatic stress disorder (PTSD) is one of the common mental disorders in military 
and veteran populations. Considerable research and clinical opinion has been focused 
on understanding the relationship between PTSD and military service and the 
implications for prevention, treatment, and management. This paper examines factors 
associated with the development of PTSD in this population, considers issues relating to 
engagement in treatment, and discusses the empirical support for best practice evidence-
based treatment. The paper goes on to explore the challenges in those areas, with 
particular reference to treatment engagement and barriers to care, as well as treatment 
non-response. The final section addresses innovative solutions to these challenges 
through improvements in agreed terminology and definitions, strategies to increase 
engagement, early identification approaches, understanding predictors of treatment 
outcome, and innovations in treatment. Treatment innovations include enhancing 
existing treatments, emerging non trauma-focused interventions, novel 
pharmacotherapy, personalised medicine approaches, advancing functional outcomes, 
family intervention and support, and attention to physical health. 
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Posttraumatic stress disorder in veteran and military populations
Posttraumatic stress disorder (PTSD) is one of the common mental disorders in 
military and veteran populations (Magruder & Yeager, 2009; Williamson, Stevelink, 
Greenberg, & Greenberg, 2018; Wisco et al., 2014). (The term “veteran” has several 
meanings in different contexts. Sometimes, for example, it refers to anyone who has left 
the military, regardless of their combat experiences and deployment history, while at 
other times it refers to anyone who has completed an operational deployment, regardless 
of whether he/she is still serving. We recognise that this causes confusion in the 
research literature and have tried, where relevant, to differentiate the two). While the 
disorder can present in mild forms, PTSD can often become a chronic disorder resulting 
in substantial functional impairment and reduced quality of life (Australian Centre for 
Posttraumatic Mental Health, 2013; Bruffaerts et al., 2012; Schnurr, Lunney, Bovin, & 
Marx, 2009). The Diagnostic and Statistical Manual of Mental Disorder 5th Edition 
(DSM-5) describes PTSD as having four symptom clusters: (1) re-experiencing the 
traumatic event, including recurring intrusive memories, flashbacks, or dreams of the 
trauma; (2) intentional avoidance of traumatic memory triggers; (3) changes in mood 
and/or thoughts, such as feelings of anxiety, sadness, shame or anger, negative thoughts 
about the self or others, or emotional numbing; and (4) hyperarousal in the form of 
irritability, hypervigilance, and trouble with concentration and sleep (American 
Psychiatric Association, 2013). The ICD-11 PTSD criteria are somewhat simpler and 
focus on the three symptom clusters of re-experiencing, active avoidance, and 
hyperarousal (Maercker et al., 2013). The DSM-5 also introduced a dissociative subtype 
characterised by high levels of either depersonalisation or derealisation. 
 PTSD is not unique to military and veteran populations. Veteran populations, 
however, are characterised by several factors that may influence the development and 
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nature of the disorder. In addition to the risk of exposure to the trauma of war, for 
example, adverse childhood experiences prior to joining the military (a risk factor for 
the development of later mental health problems) are reported at increased rates among 
those who have served in the military (Blosnich, Dichter, Cerulli, Batten, & Bossarte, 
2014). Transition to and from military life creates many adjustment challenges, 
potentially disrupting identity and increasing risk for development of mental health 
problems. Military populations report higher rates of musculoskeletal conditions and 
chronic pain than civilian controls, and chronic physical disorders have been shown to 
precede depression and anxiety in many cases (Andersen, Wade, Possemato, & 
Ouimette, 2010; Thompson t al., 2016). This combination of mental and physical 
health conditions has a synergistic effect on functional impairment (especially in 
military roles) which, in turn, may significantly contribute to worsening of mental 
health problems in veterans (Thompson t al., 2015).
Taken together, those factors represent a unique risk profile for the development 
of mental health problems among military and veteran populations. Once problems 
develop, cultural factors may affect the person’s willingness to acknowledge mental 
health issues, as well as how those problems are expressed (Sharp et al., 2015), 
highlighting the need for specialised understanding among practitioners about military 
service and the need to build trust with veterans in clinical settings. Those factors, of 
course, may also adversely affect engagement in, and response to, treatment. Without 
effective engagement, individuals with PTSD (whether military or civilian) are at risk of 
a chronic course and long duration of illness with significant negative consequences for 
themselves and their families. Regrettably, a detailed discussion of the impact on 
families is beyond the scope of this paper. Suffice to say at this point, however, that it is 
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of the utmost importance to actively support families – both in their own right and as 
part of PTSD recovery for the service member (Fear et al., 2018).
Trauma exposure and prevalence of PTSD in military and veteran 
populations
Military-related PTSD can be the result of a diverse range of operational 
experiences including combat, peacekeeping and humanitarian deployments, as well as 
non-deployment trauma. Traumatic exposures may include direct threat to the self or 
others, or witnessing significant human suffering and being prevented through rules of 
engagement from intervening to protect non-combatants. Many of these scenarios are 
characterised by moral ambiguity and complexity. There is increasing recognition of 
moral injury – the psychological, social and spiritual impacts of exposure to traumatic 
events that transgress deeply held moral beliefs (Litz et al., 2009) or involve betrayal of 
“what’s right” (Shay, 2014). These exposures can occur repeatedly against a 
background of long periods spent in demanding operational contexts, high levels of 
threat, and hostile physical environments.  
Military personnel operating in a combat role have an increased likelihood of 
developing PTSD (Prigerson, Maciejewski, & Rosenheck, 2001). However, not all 
military trauma is deployment related. Non-deployment stressors are part of everyday 
military life, including realistic training exercises conducted under extreme conditions, 
often with dangerous machinery and live ammunition, in order to prepare them for their 
roles in operational environments. Military sexual trauma (MST), which affects both 
men and women (although proportionately more women), is associated with increased 
risk of PTSD as well as other comorbidities (Kimerling et al., 2010; Wilson, 2018).  
Inevitably, as a military career progresses, there is increased likelihood of experiencing 
multiple potentially traumatic events, putting individuals at greater risk of the effects of 
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cumulative trauma exposures. A more sophisticated understanding of trauma exposures 
in military experiences beyond the warzone has been influential in informing treatment 
approaches to military-related PTSD.
Estimates of PTSD prevalence in veteran populations vary widely depending, 
for example, on the era, the percentage of those who deployed, and the specific nature 
of the deployment. For the veteran population as a whole (i.e., across cohorts and 
including both deployed and non-deployed), the best estimates are usually around 8% 
lifetime and 5% current PTSD (Wisco et al., 2014). These prevalence rates are 
comparable to, or slightly higher than, those for civilian populations (Chapman et al., 
2012; Kessler, Petukhova, Sampson, Zaslavsky, & Wittchen, 2012; Woodhead et al., 
2011). Specific deployments, however, can be associated with substantially higher rates, 
with estimates of lifetime PTSD prevalence varying up to 35% (O'Toole, Catts, Outram, 
Pierse, & Cockburn, 2009; Xue et al., 2015). Experiences on deployment, such as 
increased combat exposure, fear of being killed or seriously injured, discharging a 
weapon, and witnessing someone being wounded or killed, substantially increase the 
risk for PTSD (Xue et al., 2015). PTSD prevalence in military and veteran populations 
also varies across nations, a function of factors such as trauma-related exposure, 
deployment length, and rank (Kok, Herrell, Thomas, & Hoge, 2012; Sundin et al., 
2014), as well as methodological variations in sampling strategy and psychometrics 
(Creamer & Forbes, 2004; Rischardson, Frueh, & Acierno, 2010; Sundin, Fear, Iversen, 
Rona, & Wessely, 2010). (We have avoided providing comparisons across nations due 
to interpretational challenges). 
Somewhat counterintuitively, PTSD prevalence is usually higher in ex-service 
populations than in currently serving cohorts (Stevelink et al., 2018; Van Hooff et al., 
2018): since veterans are no longer exposed to military stressors, and should benefit 
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from the effects of a natural recovery process, one might expect PTSD rates to be lower 
in veterans. The explanation may lie in the additional stress faced by veterans as they 
swap the structure and security of the military for civilian life (e.g., finding jobs and 
accommodation, budgeting, and forming civilian relationships), which may provide 
time and space for past experiences (including traumatic events) to dominate 
consciousness. It may also be that personnel who develop substantial PTSD 
symptomology in service are more likely to leave resulting in higher rates of PTSD in 
the ex-service population. Research has also explored PTSD prevalence in specific 
military and veteran sub-populations, including peacekeepers (Souza et al., 2011) and 
military personnel (particularly women) who have experienced MST (Kimerling et al., 
2010), with results showing significant levels of PTSD even in the absence of combat 
exposure. 
Notwithstanding the heterogeneity in PTSD prevalence research, there is 
sufficient consistency to conclude that, in the majority of Western countries: a) PTSD 
remains one of the common mental disorders in both military and veteran populations; 
b) PTSD rates increase in proportion to potentially traumatic event exposure (including 
combat); and c) prevalence is higher among discharged veterans than among active duty 
military.
Questions of Causality: Risk indicators and risk factors for military-related 
PTSD
Risk factors are antecedents that contribute causally to the condition of interest, 
in this case PTSD, while risk indicators are characteristics of subgroups in whom the 
condition of interest is more common but where evidence of causality remains uncertain 
(American Psychiatric Association, 2013). PTSD appears to arise in individuals owing 
the interaction of multiple causal risk factors. While numerous risk indicators have been 
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9
identified, PTSD causality is not yet fully explained. Exposure to a traumatic event is 
required as part of the diagnostic criteria for PTSD. Yet, while PTSD is a common 
cause of morbidity in military and veteran populations, the majority of those exposed to 
potentially traumatic events do not develop PTSD. Thus, exposure to a traumatic event 
is a necessary but not sufficient risk factor in understanding individual risk for 
developing PTSD. The onset of PTSD is influenced by a complex interaction of 
biological, cognitive, and psychosocial factors across various time points. Research 
suggests that, as with civilians, a whole life approach to understanding risk for PTSD is 
required, since risk indicators have been identified in pre-trauma, peri-trauma, and post-
trauma time periods (Brewin, Andrews, & Valentine, 2000). The person’s stage of life 
and developmental tasks at the time of trauma exposures and recovery feed into this 
complex mix.  In addition, the risk factors for the development of PTSD are not 
necessarily the same as the risk factors for chronicity (Schnurr, Lunney, & Sengupta, 
2004). 
Commonly cited pre-trauma risk indicators in military and veteran populations 
include age, gender, race, education, and military status (M. Jones et al., 2013; Xue et 
al., 2015). Research has consistently shown that childhood trauma is a significant risk 
factor for later development of PTSD and, as noted above, military and veteran 
populations are more likely to report adverse childhood experiences. Sleep problems are 
also associated with, or potentially an early marker for, development of  PTSD both at 
pre- and post-deployment (Gehrman et al., 2013; Wang et al., 2018). 
Aspects of military service independent of deployment may influence the risk of 
developing PTSD, with factors such as service branch, rank, quality of leadership, 
social support, and unit cohesion proving relevant (Anderson et al.; N. Jones et al., 
2012; Wright, Kelsall, Sim, Clarke, & Creamer, 2013). Similarly, historical overviews 
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addressing the issue of combat motivation and breakdown suggest that broader 
consideration should be given to the influence of the group and the key social 
connections between serving personnel as an important moderator of vulnerability 
within the military and following discharge  (Janowitz & Shils, 1948; Wessely, 2006). 
Wessely argues that risk of psychological injury increases when the primary 
relationships of small fighting units are poor or fractured, or the unit is rendered 
ineffective, and individuals become isolated and lose their sense of connection to a 
powerful group. This possibility is supported by social network analyses in civilian 
contexts that fractured social networks following trauma increases risk for PTSD 
(Bryant et al., 2016). Indeed, given that unit cohesion and leadership are integral to 
occupational health in the military (Adler & Castro, 2013), they provide a potential 
avenue for reducing the risk of PTSD and enhancing adjustment following exposure to 
potentially traumatic events. 
Trauma related risk factors in military and veteran populations include the extent 
of exposures, length of deployments, time between deployments, and (in most cases) 
number of deployments (Bliese, Thomas, McGurk, McBride, & Castro, 2011; Rona et 
al., 2014), mirroring civilian research indicating the cumulative risk effects of repeated 
trauma exposure. Post-trauma risk factors include concurrent and subsequent life 
stressors and post-deployment support, both within and outside the military 
environment. This is particularly critical during the adaptation period during transition 
to civilian life.
PTSD is often associated with other health problems. Comorbidity of psychiatric 
disorders is common, particularly depression, anxiety disorders, and substance use 
disorders, with co-morbidity more the rule than the exception (Head et al., 2016; Smith, 
Goldstein, & Grant, 2016). Chronic physical health conditions, medically unexplained 
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somatic symptoms and chronic pain also are recognized PTSD risk indicators (NICE, 
2018). However, the nature and direction of causal relationships between PTSD and 
physical health status remain largely unexplored (Gautam, Jain, Gautam, Vahia, & 
Grover, 2017; McFarlane, Lawrence-Wood, Van Hooff, Malhi, & Yehuda, 2017). 
Suicidal ideation and attempts, although not exclusively related to PTSD, have also 
been the focus of considerable attention in recent years (Naifeh, Mash, et al., 2018; 
Naifeh, Ursano, et al., 2018). Significant functional impairment is common in the form 
of problematic relationships, reduced social networks, and poorer employment 
outcomes (Rona et al., 2009; Schnurr et al., 2009). 
The current status of PTSD treatments
Earlier international PTSD treatment guidelines consistently found trauma-
focused cognitive behavioural therapies, such as Cognitive Processing Therapy (CPT), 
Prolonged Exposure (PE) and Eye-Movement Desensitization and Reprocessing 
(EMDR) to be the gold standard for treatment (Australian Centre for Posttraumatic 
Mental Health, 2013). More recent guidelines expand the number of treatments with 
high levels of evidence. For example, the guideline jointly developed by the Department 
of Veterans Affairs and the Department of Defense (2017) in the US gave the strongest 
recommendation to trauma-focused psychotherapies such as PE, CPT, and EMDR, but 
also included a range of additional therapies in this recommendation (e.g., written 
narrative exposure, Brief Eclectic Therapy). The recent update of the UK National 
Institute for Clinical Excellence (NICE) PTSD Guideline differs slightly in endorsing 
PE and CPT with the strongest recommendations but giving a slightly lower rating to 
EMDR specifically in relation to military veterans who have been traumatised as a 
result of combat, in view of the more limited evidence base for EMDR in this 
population (NICE, 2018). Taken together, the consistent findings across several 
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guidelines from different countries recommend that trauma focussed psychological 
interventions should be the first line treatment for PTSD. 
PTSD guidelines and meta-analyses (e.g., N. Jones, Burdett, Green, & 
Greenberg, 2017; Lee et al., 2016) have generally reported smaller clinical effects in 
pharmacotherapy than trauma-focused interventions. Increasing attention, however, is 
now being paid to the methodologies of studies included in those reviews. For example, 
the meta-analysis of these comparisons by Lee et al. (2016), while supporting the use of 
trauma focused interventions as first line, recommended the need for more direct head 
to head research with specific agents, as well as the need to prioritise studies utilising 
active controls instead of waitlist or treatment-as-usual conditions (Lee et al., 2016). 
Consistent with this, new evidence indicating little difference between sertraline plus 
enhanced medication management, PE plus placebo, and PE plus sertraline (Rauch et 
al., 2018) suggests that, as the direct comparison evidence base firms, more nuanced 
recommendations will emerge. Despite this, all current guidelines continue to 
emphasise the role of medication and recommend its use, where indicated, in 
stabilisation or where first-line treatments are not available, not acceptable, or have not 
worked.  
The intensive treatment outcome research efforts in recent years, using high-
quality randomised controlled trials, is commendable. Regrettably, however, research 
suggests that military and veteran populations experience more modest treatment 
outcomes than civilians, with around two-thirds retaining their PTSD diagnosis after 
treatment with CPT or PE (Steenkamp, Litz, Hoge, & Marmar, 2015). In view of these 
modest outcomes, modifications to standardised treatment may be required in clinical 
practice to suit the specific presentation. Promising early results, for example, have been 
found in the treatment of moral injury with veterans (Litz, Lebowitz, Gray, & Nash, 
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2017). Similarly, although more research is required, it is reasonable to assume that the 
presence of significant dissociation would have implications for treatment (Frewen & 
Lanius, 2015). Interestingly, one study found that female veterans who met criteria for 
the dissociative subtype of PTSD had reduced, but still meaningful, response to PE 
(Wolf, Lunney, & Schnurr, 2016).
Challenges in providing evidence-based treatments
Significant challenges exist in delivering evidence-based treatments to military 
and veteran populations. Pathways to care comprise multiple steps, including 
acknowledging the problem, making a decision to enter treatment, accessing care, and 
remaining in treatment. A multitude of potential barriers to care exist at each step 
(Forbes et al., 2018). Some of the key challenges in delivering evidence-based 
treatments to military and veteran populations with PTSD include: a) engagement and 
retention in treatment; b) absence of defined benchmarks for assessing treatment 
progress and non-response; and c) clinician-related barriers including reluctance by 
some to work with veteran populations, capability and willingness to use evidence-
based treatments, and degree of treatment fidelity. The section below expands on these 
key barriers to effective care, of which stigma is a prominent one, before providing a 
framework for future research in order to best respond to these challenges.
Treatment engagement
Elements of military culture and organisation, as well as individual factors, can 
make help-seeking and treatment engagement a challenge. Engaging in help-seeking 
behaviours, and the associated perceived vulnerability, can be experienced as 
antithetical to the warrior ethos universal to all militaries that prize self-reliance and 
strength in the face of adversity. Combined with a tendency to externalise, this may 
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make it difficult for military personnel and veterans to acknowledge problems even to 
themselves and, if they do acknowledge them, to refuse mental health care on the 
grounds that they would rather handle the problem on their own (Naifeh et al., 2016). 
Further research is needed to better untangle the complexity of this preference for self-
management  in order to increase help-seeking behaviours and modify the way in which 
services are delivered (Adler, Britt, Riviere, Kim, & Thomas, 2015). 
A further concern for serving members (as well as some emergency responders) 
is that engaging in PTSD treatment may have a negative effect on career trajectory 
(Coleman, Stevelink, Hatch, Denny, & Greenberg, 2017; Iversen et al., 2011). Some of 
these concerns are well-founded, as certain mental health problems and medication use 
can result in being assessed as unfit to deploy. Other concerns, such as being treated 
differently by leadership or fellow unit members, may or may not be justified yet the 
broad issue of stigma is clearly relevant (Sharp et al., 2015). Cultures, beliefs, and 
behaviours around help-seeking that develop in military service may become ingrained, 
remaining after transition out of the military (Sharp et al., 2015). There is some 
evidence that stigma is not a ‘fixed’ entity and, indeed, may be highest whilst service 
personnel are on deployment (Osório, Jones, Fertout, & Greenberg, 2013). This may be 
because deployed personnel develop an adaptive strong ‘operational mindset’ which 
allows them to focus on the various challenging tasks they are required to undertake 
whilst deployed. Such a mindset is unlikely to include positive attitudes towards help-
seeking. The concept of stigma relates both to ‘self-stigma’ (the individuals’ own 
beliefs and agreement with stereotypes they perceive others apply to themselves), and 
‘anticipated public stigma’ (the manner in which they believe they will be viewed by 
others) (Forbes et al., 2018; Hoge et al., 2004; McFarlane, Hodson, Van Hooff, & 
Davies, 2011). Both types may impede help-seeking behaviour.
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The nature of PTSD itself may also impede engaging in treatment (Blais, 
Hoerster, Malte, Hunt, & Jakupcak, 2014). A cardinal feature of the disorder is 
avoidance and it is not unusual for people with PTSD to go to extreme lengths in order 
to avoid reminders of their traumatic experience. Many treatments for PTSD, of course, 
require people to do the exact opposite and to confront the memory of their traumatic 
experiences repeatedly, and in rich sensory detail. Thus, avoidance may contribute to 
failure to engage in treatment, early drop out, and a delayed return to treatment. Finally, 
involvement in adversarial liability and compensation processes can contribute to delays 
and interruptions in treatment, potentially undermining recovery. Any process that 
prolongs symptoms and disability arising from PTSD will reduce opportunities for the 
individual to modify, re-focus, or substantially change their vocational goals.  
Movements internationally toward non-liability approaches to health care (i.e., 
automatic approval for treatment without going through a lengthy claims process) have 
helped to separate treatment seeking from compensation, hopefully reducing this 
potential barrier to care.  
Primary care (in both military and civilian contexts) deserves special mention, 
since this will be the first point of contact for many people with PTSD or other mental 
health conditions. PTSD recognition, and patient engagement, can present major 
challenges for primary care providers. PTSD may present in a wide variety of ways. It 
could, for example, be just one of many differential diagnoses of nonspecific symptoms 
or a masked factor complicating the care of physical health conditions. It could manifest 
as late onset, remote from psychologically traumatic events, or as complex PTSD in 
persons with ongoing psychologically traumatic stressors. As the health practitioner 
most likely to be delivering initial and ongoing care, as well as providing referrals for 
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specialist mental health care, primary care providers need to find ways to recognise 
possible PTSD among a potentially complex array of clinical presentations.
Treatment non-response
“Head to head” comparisons of veterans and civilian patients have not been 
conducted and conclusions, therefore, must be drawn with caution. Nevertheless, 
observation of clinical effect sizes in the treatment outcome literature from several 
countries (e.g., Australia, US, Canada) suggests a poorer treatment response among 
military personnel and veterans compared to other trauma populations (N. Jones et al., 
2017). High comorbidity may be a contributing factor, with military PTSD associated 
with high levels of problematic anger, substance abuse, sleep disturbance and emotional 
numbing (Knowles, Sripada, Defever, & Rauch, 2018). Personality style and military 
training (good soldiers may not necessarily make good patients), trauma history, over-
representation of males, and differences across service delivery systems may all play a 
part in these somewhat disappointing outcomes. Despite recognition of the complexity 
and poor treatment response in military and veteran PTSD, there is little evidence and 
guidance to support sound clinical decision making when an individual: a) has an 
atypical presentation; b) has a complex presentation including several comorbidities 
and/or psycho-social problems that challenge considerations in how to sequence 
treatment; and/or c) does not respond to first or second-line treatments. 
One outstanding question in the field is how to correctly identify treatment-
resistant PTSD. This contrasts with other disorders such as depression which have 
clearly developed heuristic definitions of treatment resistance (McFarlane, 2019) and 
have adopted clinical algorithms that guide clinicians through the decision-making 
process of ‘next steps’ when treatment is ineffective and a change of treatment plan is 
indicated (Gautam et al., 2017). Sippel and colleagues (2018) have recently offered 
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guidance on how to define treatment resistant PTSD, but evidence is needed to inform 
the appropriate action in the context of non-response to treatment. As noted below, 
recent moves towards personalised medicine may have relevance in this context.
Clinician-related barriers
 The quality of the therapeutic relationship is a key factor in achieving positive 
outcomes. To work effectively with military and veteran populations, practitioners need 
an understanding of military culture and have the capacity to tolerate details of 
traumatic experiences whilst maintaining unconditional positive regard (Australian 
Centre for Posttraumatic Mental Health, 2013). In addition to consideration of the 
therapeutic relationship, the skills needed to deliver trauma-focused treatments are time-
intensive and expensive to obtain. Research suggests that, even after a clinician has 
been appropriately trained in trauma-focused treatment, the uptake and implementation 
with military and veteran populations with PTSD is poor (Rosen et al., 2017; Rosen et 
al., 2016). There are several reasons why clinicians might be hesitant to use evidence 
based interventions, including doubts about the effectiveness of trauma-focused 
treatments and concerns about distressing the patient with recounting and recalling the 
traumatic memory.
Maintaining the fidelity of PTSD treatment protocols in real world clinical 
settings is always a challenge, as practitioners adapt the protocols to suit specific 
clinical presentations, including the unique features of military and veteran populations 
(Cook, Dinnen, Thompson, Simiola, & Schnurr, 2014). Perhaps not unreasonably, when 
veterans do not respond to first-line treatments, and in the absence of evidence-based 
clinical decision algorithms for treatment resistant PTSD, clinicians may seek 
alternative approaches to treatment. While some of these options may be clinically 
appropriate, others may be of little therapeutic benefit and there is a risk of long 
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treatment episodes that achieve little. As a result, implementation of treatments that 
work, as well as maintaining patients in these treatments, is becoming an increasing 
focus and cause for concern, in addition to concerns regarding the quality and impact of 
the treatments themselves (Sippel et al., 2018; Stirman et al., 2017).
Innovative solutions to PTSD treatment challenges
The current challenges in PTSD treatment require development of scientifically 
robust innovations that are consistent with the priorities of military personnel and 
veterans, and accessible to them across nations. We will now explore possible research 
directions necessary to progress this agenda over the next decade.
Agreed terminology and definitions 
A clear consensus on what constitutes PTSD treatment success, treatment failure 
and/or non-response, treatment resistance, and cure and/or remission, along with an 
agreed terminology, is essential. A fundamental problem at present is how to 
operationalise when a person has had sufficient treatment.  Varying definitions exist and 
are not used systematically across studies (Schnurr & Lunney, 2016; Sippel et al., 
2018). Operationalisation of these constructs will facilitate development of clinical 
algorithms to guide decision making and treatment planning in cases of treatment non-
response, treatment resistance, or relapse.
Strategies to increase engagement
Strategies to enhance engagement include increasing individual awareness of the 
need for treatment, reducing stigma, alternative methods of healthcare delivery, 
enhancing treatment acceptability and accessibility, and involving families, military 
leaders and communities in sustaining an environment supportive of care. A better 
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understanding of the many steps in the pathway to care is needed in order to effectively 
target strategies to increase engagement at all levels. These improvements could be 
facilitated through leadership initiatives, unit-based bystander support, and family 
involvement, as well as through strategies designed to increase awareness of the 
benefits of PTSD treatment. 
Systemic changes are required to improve the coordination and integration of 
healthcare services within and between military and veteran systems, as well as to 
improve accessibility, quality, and resourcing of those services. Such systemic 
improvements are particularly important during key transition periods. The 
organisational culture needs to actively promote engagement in treatment when 
required, from the highest levels of leadership through various command levels, to 
leveraging unit and “buddy” support. Peers (i.e., “buddies” and “mates”) can be 
particularly important in encouraging engagement in care. Emerging research 
examining the effectiveness of peer led engagement and help promoting activities 
following exposures are demonstrating promise and warrant further investigation (N. 
Jones et al., 2017). 
Identifying who will benefit from intervention is a key component of 
engagement. While population screening has been considered, large automated 
screening trials have demonstrated little impact on treatment seeking (Rona et al., 
2017). Face to face engagement with healthcare professionals, often including education 
and some psychometric screening, is currently delivered in several Defence Forces, with 
the goal of facilitating early detection, case identification, and engagement in treatment 
if required. Such approaches are commonly applied to cohorts at specific timepoints 
(e.g., following deployment, at the point of transition) and, when indicated, in primary 
care settings. Studies building on the work of Rona et al. (2017) to examine the 
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effectiveness of different elements provided in current face to face engagement and 
screening practices are critical to ensure that scarce resources are devoted to where the 
gains will be most substantial (McFarlane 2017). An integrated approach to identifying 
mental health problems, which may include screening across the deployment cycle is 
needed to facilitate continuity of care from garrison to deployment and back again 
(Warner, Appenzeller, Parker, Warner, & Hoge, 2011).  
On a related theme, it may be possible to go beyond screening based purely on 
self-report to explore other risk markers. While military personnel can develop PTSD 
after a single incident during service, there is increasing recognition that repeated 
deployments confer an incremental risk of developing PTSD (McFarlane et al., 2011). 
Conceptualising PTSD within a staging model, whereby trauma exposed individuals 
have not developed symptoms but are at greater risk due to high likelihood of further 
exposure and are presenting with certain biomarkers, may provide opportunity for early 
engagement and avoid the complications, comorbidity, and psychosocial losses 
associated with chronicity and a prolonged recovery process (McFarlane et al., 2017). It 
is unclear, however, how effective these interventions might be in returning personnel 
to full function and studies are required to properly understand the occupational 
prognosis of trauma-related adjustment disorders which develop during service, with or 
without early intervention.
Collaborative care models in primary care (e.g., a multidisciplinary team 
approach), which have a strong evidence base in mental health (Archer et al., 2012), 
may assist with increasing engagement in PTSD treatment, helping to efficiently 
identify PTSD patients and match care according to clinical complexity and patient 
characteristics (Engel et al., 2016). Emerging evidence around case management has 
significant promise for high risk and complex cases (Kehle-Forbes & Kimerling, 2017).  
Page 21 of 36
URL: http://mc.manuscriptcentral.com/cirp  Email: cirp-peerreview@journals.tandf.co.uk
International Journal of Psychiatry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
21
However, trials of collaborative care for PTSD have yielded mixed results, and point to 
the importance of ensuring that collaborative care involves effective treatments 
(Schnurr, 2016; Schnurr et al., 2013).
Modifications to PTSD treatments or healthcare service structures also have the 
potential to increase military and veteran engagement with PTSD treatment. Massed 
treatment, for example, such as intensive PE (Foa et al., 2018) and CPT or CT (Ehlers et 
al., 2014), may be appealing to military personnel who may have limited availability for 
lengthy treatment periods. Another potential treatment modification, designed to 
improve maintenance of treatment gains, is booster sessions after treatment completion. 
Little evidence is available r garding the long-term benefits of treatment for PTSD 
because most trials only assess outcomes in the short and medium term, but the few 
long term follow-ups that exist suggest initial treatment gains may not be maintained 
over time (Resick, Williams, Suvak, Monson, & Gradus, 2012; Shalev et al., 2016). 
Booster sessions may provide beneficial refresher training of skills taught in therapy, 
and lead to greater symptom reduction in the long-term. In addition, continued 
expansion of telehealth and related modalities may assist in making evidence-based 
treatment, educational activities, and research participation more accessible.  
Improved understanding of treatment outcome predictors
Research focused on uncovering predictors of treatment outcome, including 
active facilitators and inhibitors of change, is vital. Loss, shame, and problematic anger 
are particularly relevant to military and veteran populations and have been demonstrated 
to be potentially important inhibitors of treatment outcomes (Forbes et al., 2005; Lloyd 
et al., 2014; Yehuda, Vermetten, McFarlane, & Lehrner, 2014). There is mixed 
evidence around the extent to which depression, guilt, anxiety, and dissociation at pre-
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treatment are associated with poorer treatment response (e.g., Richardson et al., 2014). 
Recent research has suggested that it may be a combination of co-occurring  risk 
indicators that best predicts outcomes (e.g., severe PTSD, guilt and depression as a co-
occurring triad) rather than single predictors considered independently (Phelps et al., 
2018). Further work is needed in developing the evidence base around differential 
treatment response in individual PTSD profiles with a view to evidence based 
guidelines for treatment sequencing and the development of interventions for clusters of 
features such as the triad outlined above. The emerging concept of moral injury and its 
implications for PTSD interventions is also relevant here (Bryan, Bryan, Roberge, 
Leifker, & Rozek, 2017). Different approaches might be required when the impact of 
traumatic experiences manifests as recognisable symptoms of PTSD (e.g., arousal) but 
the mechanism of action driving symptoms is markedly different (e.g., not fear of harm 
but beliefs about transgressions of core beliefs or perceived betrayals by self or others – 
moral injury; Williamson, Stevelink, & Greenberg, 2018). 
Innovations in treatment
Now that the evidence base for first-line treatments of PTSD is established, 
increasing attention is being paid to related questions. The following are important areas 
for further research: a) how to improve, complement, and augment current evidence-
based treatments to maximise treatment response; b) expanding knowledge about non-
trauma focused treatments; c) novel pharmacotherapy; d) personalised medicine 
approaches; and e) treatments that specifically aim to enhance functioning.
i) Enhancing existing treatments 
Research must continue to focus on strategies designed to prepare an individual 
for treatment, better engage an individual in treatment, or augment the effects of current 
treatments. Advances in neuroscience, cognitive psychology and pharmacology have 
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produced several novel approaches to augmenting current PTSD treatments that can be 
used concurrently with trauma-focused treatments or in a preparatory fashion. Examples 
include pharmacological approaches such as MDMA, ketamine, and LSD, which, when 
used in conjunction with unstructured psychotherapy, may facilitate engagement with 
the traumatic memory (Mithoefer, Grob, & Brewerton, 2016). Further work is also 
underway in combining MDMA with evidence based trauma focused treatments. The 
use of propranolol, a noradrenergic beta-receptor blocker, as a putative reconsolidation 
blocker in conjunction with psychotherapy also shows some promise in reducing PTSD 
symptoms (Brunet et al., 2018). 
Recent developments in cognitive and neuroscientific interventions that aim to 
enhance working memory or improve attention control (McDermott et al., 2016),  
transcranial magnetic stimulation (TMS; Kozel et al., 2019), and new technologies such 
as virtual reality (Reger et al., 2016) hav  also shown promise as augmentation 
interventions. 
Given the evidence indicating that anger inhibits treatment response in PTSD, 
using targeted anger interventions in a phased approach prior to trauma focused 
treatment may offer benefit (Cash et al., 2018). Experiential and physical treatments 
such as physical exercise or creative art therapies, and current second-line treatments 
such as acupuncture or mindfulness, may have a role to play in augmenting existing first 
line treatments (as well as potentially treatments in their own right). While these 
approaches may be more acceptable to some service members, their effects on 
improving PTSD are not well studied (Benedek & Wynn, 2016).
ii) Non-trauma-focused treatments
Current promising non-trauma-focused treatments for PTSD include 
Interpersonal therapy (Markowitz et al., 2015), Mindfulness-Based Stress Reduction 
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(Polusny et al., 2015), and Present-Centred Therapy (Schnurr et al., 2007), which was 
initially conceptualised as a control treatment. Emerging evidence in neurofeedback and 
biofeedback is also showing promise (Fisher, Lanius, & Frewen, 2016). As noted above, 
although it is not yet known whether these non-trauma focus interventions will improve 
outcomes for military personnel or veterans who do not respond to first-line treatments, 
they may be more acceptable to those who express a strong preference not to engage in 
trauma focused work. Similarly, in recognition that PTSD is often  comorbid with other 
psychiatric disorders, transdiagnostic approaches are becoming increasingly considered 
as a useful approach for trauma related pathology (Gutner, Galovski, Bovin, & Schnurr, 
2016). 
iii) Novel pharmacotherapy
A common theme in recent literature is the disappointing lack of innovation in 
the development of effective pharmacotherapy for PTSD (Krystal et al., 2017).  
Antidepressants targeting traditional monaminergic systems, in particular selective 
serotonin reuptake inhibitors, remain the first line evidence-based treatments when 
considering medications.  Given the limited effect size of agents like the SSRIs (Ipser & 
Stein, 2012) and the absence of a PTSD-specific agent, a range of agents predominantly 
designed for other mental health conditions have also been trialled or frequently utilized 
including other antidepressant, anxiolytic and antipsychotic medications. At this point, 
none have reached established high level evidence. Work is currently underway, 
however, focussing on non-monoaminergic transmitter systems that may be of specific 
relevance to the neurobiology of PTSD. A recent expert consensus identified a list of 
mechanisms that should be targeted for ongoing research, with the top three being 
NMDA receptor antagonists, cannabinoid receptor modulators, and glucocorticoid 
receptor agonists (Krystal et al., 2017).
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iv) Personalised medicine  
Personalised medicine in PTSD, where treatments are tailored to match the 
specific needs of an individual military member or veteran, holds considerable promise. 
This work now goes well beyond the traditional genomic focus of personalised 
medicine. Research is needed on how to improve treatment fit and effectiveness through 
better understanding of the typologies of PTSD phenotypes and across the 
biopsychosocial indicators. Advances in use of fMRI, EEG, biomarkers and genetics 
hold some promise also for improved understanding of neurobiological profile 
variations and the for potential matching and tailoring interventions. In addition, large 
randomised controlled trial datasets using first-line treatments such as PE and CPT 
(Schnurr et al., 2015) could form a base for machine learning approaches to identify 
which interventions work for whom. This “big data” research can then drive appropriate 
adaptations to the treatment protocols or the clinical setting and provide informed 
guidance for treatment selection through data-driven, continuous quality improvement 
(Cook et al., 2014). Machine learning approaches to large data may aid in moving 
PTSD to personalized medicine, matching the individual with the most likely successful 
treatment. 
v) Approaches specifically designed to enhance functioning
Since PTSD is routinely associated with impaired social and occupational 
functioning, it is critical to develop and rigorously evaluate interventions designed to 
have a broader social-occupational focus on wellbeing and function (examples include 
not only occupational rehabilitation, but also support animals, equine therapy, and 
hiking). Such interventions have the potential to provide avenues to engagement in 
activity, positive social connections and regaining a sense of self beyond the mental 
health problems. Indeed, such interventions may succeed where traditional approaches 
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have been unsuccessful, including in preparatory phases prior to first line treatments. In 
the absence of robust evidence, however, it is important that these approaches are not 
considered as a substitute for evidence based interventions. Psychological wellbeing is 
strongly influenced by participation in life roles, but ensuring role participation 
requires: (a) recognising, diagnosing and effectively treating the condition so as to 
minimize impairments; (b) enabling adaptive coping for those living with the condition; 
and (c) reducing barriers to role participation in their social and physical environments.
vi) The role of family intervention and support
While the impact on families is beyond the scope of this paper, it is nevertheless 
important to recognise the difficulties faced by family members of military personnel 
and veterans with PTSD. How do we care for the wellbeing of families as an end goal in 
of itself, and how do we improve their wellbeing in a way that supports the veteran’s 
recovery? Research consistently finds that support and encouragement from loved ones 
increases treatment initiation and retention in military and veteran populations (Murphy, 
Palmer, Hill, Ashwick, & Busuttil, 2017). The burden of care shouldered by the families 
of those with PTSD is substantial and the impact on their own mental health needs must 
be assessed in order to minimise long term negative consequences for the PTSD sufferer 
and the family (Cramm, Mahar, MacLean, & Birtwhistle, 2019; Fear et al., 2018). 
vii) Attention to physical health
Specialist mental health providers and researchers are sometimes at risk of 
focussing exclusively on psychiatric conditions and ignoring the role of chronic 
physical health conditions, medically unexplained symptoms, and chronic pain. Those 
three types of problems are disproportionately prevalent in persons with PTSD (as, 
indeed, they are in persons with depression or anxiety disorders). Whole person 
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management must include attention to comorbid/co-occurring physical health problems 
in addition to the psychiatric condition (Sharp, 2019).
Strengths and Weaknesses
The author group of this paper was convened by the 5 Eyes Mental Health 
Research and Innovation Collaborative (5 Eyes MHRIC). The 5 Eyes MHRIC is a 
collaboration of mental health researchers in Canada, Australia, the United States, the 
United Kingdom and New Zealand working to improve mental health outcomes for past 
and present military personnel and their families. The paper reflects interpretations of 
the evidence base by a group of researchers working on military and veteran mental 
health in those countries and might not represent the views of other researchers. 
However, the broad representation of disciplines, nationalities and military and veteran 
life course stages mitigates the risks of bias.
Summary and Conclusions
Research over the past decade has demonstrated that evidence-based treatments, 
when used correctly, can be moderately effective for treating PTSD in military and 
veteran populations. Improvements in symptom reduction and quality of life for some 
individuals are modest, however, highlighting the need for improved PTSD treatment 
and chronic symptom management approaches.  
This paper has provided an overview of key questions in each of several 
important areas for future research including: a) developing a consensus on terminology 
and definitions around treatment success, failure and/or non-response, resistance, and 
cure/remission; b) developing individual and systemic approaches to enhancing 
treatment engagement, including addressing stigma, improving early recognition, and 
modifying treatment; c) improving our understanding of predictors of treatment 
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outcome; d) improving the efficacy of treatment through enhancing existing 
interventions, exploring new approaches, increasing personalised approaches to 
treatment, and increasing the focus on functional impairment and physical health. 
We also do not underestimate the scale of this important task. We also recognise 
that research directions will continue to be driven, in large part, by the individual 
interests of researchers, by the availability of targeted research funding, and by various 
social and government priorities. Nevertheless, we believe that the future directions 
outlined in this paper will inform key developments in each of the nominated areas. The 
authorship group is are committed to ongoing international collaboration with a view to 
optimising a consistent and coherent approach to research and policy in military and 
veteran mental health. 
The agenda for future research needs to be ambitious, focussing on international 
cooperation and extending the focus beyond a “one-size-fits-all” approach in order to 
tailor treatment to individual need. Only then will we ensure better mental health 
outcomes for serving personnel, veterans, and their families.
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